Podwińska Ewa, Knapik Piotr, Bednarski Piotr K, Wiklińska Agnieszka
Słaskiej Akademii Medycznej, Katedry Anestezjologii i Intensywnej Terapii w Zabrzu.
Wiad Lek. 2002;55(7-8):411-5.
Unbalanced hyperthyroidism leads to the feeling of dyspnea and to the decrease of vital lung capacity. Efficacious treatment of thyrotoxicosis relieves mentioned disorders and brings normalization of ventilation parameters. The main issue of this research was the analysis of vital lung capacity in female patients with properly treated hyperthyroidism and comparison of values of these parameters among patients with balanced thyrotoxicosis, non-toxic goitre and with non-thyroid disorders. Research was conducted on 300 randomized female-patients (ASA I, II), aged 18 to 47 with surgically treated hyperthyroidism, non-toxic goitre or non-thyroid disorders. Vital lung capacity (VLC) was analyzed as absolute values and as a percent of predicted values. Statistical analysis revealed that patients in specified groups did not differ in age, weight and frequency of belonging to both ASA categories. Vital lung capacity and percent of predicted values were not significantly different in all groups. Vital lung capacity of female-patients with balanced hyperthyroidism did not differ significantly from vital lung capacity of patients with non-toxic goitre and non-thyroid disorders.
甲状腺功能亢进失衡会导致呼吸困难，并使肺活量降低。有效治疗甲状腺毒症可缓解上述病症，并使通气参数恢复正常。本研究的主要问题是分析经过适当治疗的甲状腺功能亢进女性患者的肺活量，并比较甲状腺毒症平衡、非毒性甲状腺肿和非甲状腺疾病患者的这些参数值。对300名随机选取的18至47岁接受手术治疗的甲状腺功能亢进、非毒性甲状腺肿或非甲状腺疾病的女性患者（ASA I、II级）进行了研究。肺活量（VLC）以绝对值和预测值的百分比进行分析。统计分析显示，特定组中的患者在年龄、体重以及属于两个ASA类别的频率方面没有差异。所有组的肺活量和预测值百分比没有显著差异。甲状腺功能亢进平衡的女性患者的肺活量与非毒性甲状腺肿和非甲状腺疾病患者的肺活量没有显著差异。
